v3.24.1.u1
SHAREHOLDERS' EQUITY (Tables)
 12 Months Ended
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of stock option activity
 
         
Weighted average
        
   
Number of options
and RSUs
    
Exercise price
    
Remaining
contractual term 

(in years)

    
Aggregate intrinsic
value
  
                         
Outstanding at January 1, 2023
    
3,064,674
    
$
1.39
      
59.70
    
$
73,284
  
Granted
    
1,276,693
      
0.01
      
-
      
-
  
Exercised
    
(1,586,980
)
    
1.33
      
-
      
50,903
  
Cancelled
    
(261,106
)
    
0.12
      
-
      
-
  
Outstanding at December 31, 2023
    
2,493,281
    
$
0.84
      
66.70
    
$
74,862
  
                                 
Exercisable at December 31, 2023
    
349,648
    
$
5.40
      
2.38
    
$
8,905
  
                                 
Vested and expected to vest at December 31, 2023
    
2,489,358
    
$
0.89
      
73.59
    
$
140,704
  
Schedule of option activity by price range
 
     

Outstanding

    

Exercisable

        
Range of 
exercise price
    
Number of 
options and 
RSUs
    
Weighted 
average
remaining 
contractual life
(years)
    
Weighted 
average
exercise price
    
Number of
 options and
RSUs
    
Weighted 
average
remaining
 contractual life
(years)
    
Weighted 
average
exercise price
  
                                       
$
0.01
      
2,121,332
      
77.98
    
$
0.01
      
-
      
-
    
$
-
  
 
2.52 – 3.38
      
105,336
      
1.39
      
3.23
      
105,336
      
1.39
      
3.23
  
 
4.25 – 5.90
      
167,884
      
2.92
      
5.26
      
167,884
      
2.92
      
5.26
  
 
6.23 – 8.34
      
72,635
      
1.86
      
6.63
      
57,635
      
2.05
      
6.65
  
$
12.02 – 21.35
      
26,094
      
4.21
      
15.34
      
18,793
      
4.20
      
15.03
  
                                                     
         
2,493,281
      
66.70
    
$
0.84
      
349,648
      
2.38
    
$
5.40
  
Schedule of stock-based compensation expense
 
   
Year ended December 31,
  
   
2023
    
2022
    
2021
  
                   
Cost of revenue
  
$
919
    
$
446
    
$
171
  
Research and development
    
2,745
      
2,129
      
946
  
Selling and marketing
    
6,995
      
4,528
      
3,248
  
General and administrative
    
4,931
      
4,467
      
2,620
  
                         
Total
  
$
15,590
    
$
11,570
    
$
6,985
  
Performance Based Stock Options Member  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of stock option activity
 
         
Weighted average
        
   
Number of
Performance based
options and RSUs
    
Exercise price
    
Remaining  
contractual term
(in years)
    
Aggregate intrinsic
value
  
                         
Outstanding at January 1, 2023
    
592,511
    
$
0.51
      
70.64
    
$
14,690
  
Granted
    
281,000
      
0.01
      
-
      
-
  
Exercised
    
(231,971
)
    
1.30
      
-
      
7,980
  
Cancelled
    
(109,512
)
    
0.01
      
-
      
-
  
                                 
Outstanding at December 31, 2023
    
532,028
    
$
0.01
      
87.53
    
$
16,424
  
                                 
Exercisable at December 31, 2023
    
-
      
-
      
-
      
-
  
                                 
Vested and expected to vest at December 31, 2023
    
456,032
    
$
0.01
      
98.40
    
$
30,501
  
Schedule of option activity by price range
 
     

Outstanding

    

Exercisable

        
Range of 
exercise price
    
Number of 
options and
RSUs
    
Weighted 
average
remaining 
contractual life
(years)
    
Weighted  
average
exercise price
    
Number of 
options and
RSUs
    
Weighted 
average
remaining 
contractual life
(years)
    
Weighted 
average
exercise price
  
                                       
$
0.01
      
532,028
      
87.53
    
$
0.01
      
-
      
-
    
$
-